See how Dexcom products can help optimise your patients' glucose control and support their quality of life.
Smart devices sold separately†
A leader in diabetes care
Dexcom is dedicated to developing innovative glucose monitoring technology and products to help patients and Healthcare Professionals improve diabetes management.
As the world's first real-time, integrated CGM (rt-iCGM), the Dexcom G6 Continuous Glucose Monitoring (CGM) System offers a range of features and benefits that help make that possible.
1st mobile CGM system
1st CGM system indicated for non-adjunctive use (insulin dosing without fingersticks*)
Redefining the CGM landscape
Dexcom delivered the next generation of CGM technology with the development of Dexcom G6: a zero-fingersticks*, accurate1 and interoperable real-time CGM (rt-CGM) system.
Formatted Block Title
Provides exceptional accuracy1
Provides exceptional accuracy1
DEXCOM G6 PERFORMANCE METRICS1
WITH AN OVERALL MARD OF 9% AND A SUSTAINED ACCURACY OVER TIME,1 THE DEXCOM G6 DEMONSTRATES EXCEPTIONAL ACCURACY.
|
%15/15 (0.8 mmol/L)ǂ |
%20/20 (1.1 mmol/L)§ |
MARD|| | |
|---|---|---|---|
| Overall (Combine study data from paediatrics and adults, see below) | 83.3% | 93.9% | 9.0% |
| Overall accuracy over time | |||
| Day 1 | 81.5% | 92.2% | 9.3% |
| Days 4 - 5 | 85.8% | 95.5% | 9.4% |
| Day 10 | 82.4% | 92.5% | 9.0% |
ACCURACY AT VARIOUS RATES OF CHANGE2
RISING OR FALLING, DEXCOM G6 DEMONSTRATES ACCURACY EVEN WHEN LEVELS RAPIDLY OR SLOWLY RISE OR FALL.2
|
CGM RATE OF CHANGE (mg/(dL · min)) |
%20/20 |
|---|---|
| < -2 | 89.7% |
| [-2, -1) | 93.0% |
| [-1,0) | 93.9% |
| [0.1) | 92.7% |
| (1,2] | 89.6% |
| > 2 | 87.1% |
Supports optimal diabetes management
Zero fingersticks*or scanning required
Smart device compatibility†
Accuracy during critical times3
Supports improved glycaemic outcomes (multiple measures)4-7
Glucose data sharing with loved ones**
Customisable high and low alerts
Interoperability in insulin delivery
Dexcom has integrated its rt-CGM technology through insulin pumps and digital health partnerships to support more customisable and convenient treatment options.
Why CGM
Dowiedz się, dlaczego system ciągłego monitorowania glikemii (CGM) jest doskonałym narzędziem pomagającym poprawić kontrolę cukrzycy.
Przejrzyj dowody demonstrujące jaki wpływ na kontrolę glikemii może mieć używanie CGM.
Twój pacjent z CT1 może odnieść korzyść bez względu na to, czy stosuje wielokrotne wstrzyknięcia, system Flash czy pompę insulinową.
* If your glucose alerts and readings from Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
† Compatible smart devices are sold separately. For a list of compatible smart devices, please visit www.dexcom.com/compatibility.
‡ % of CGM readings within ±15 mg/dL of YSI lab reference values ≤ 100mg/dL or ±15% of YSI values > 100mg/dL.
§ Analogous to %15/15 (see previous footnote).
II MARD is a statistical measure of accuracy; the lower the number, the better.
** Internet connectivity required for data sharing. Following requires the use of the Follow App. Followers should always confirm readings on the Dexcom G6 App or Receiver before making treatment decisions.
1 Shah VN, et al. Diabetes Technol Ther. 2018.
2 Wadwa RP, et al. Diabetes Technol Ther. 2018.
3 Dexcom G6 CGM System User Guide, 2018.
4 Beck RW, et al. JAMA. 2017;317(4):371-378.
5 Reddy M, et al. Diabet Med. 2017.
6 Heinemann L, et al. Lancet. 2018.
7 Welsh JB et al. Diabetes Technol Ther 2019;21(3):128-32.